Ingevity Corporation
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- David H. Li
- Full Time Employees
- 1,500
- Sector
- Process industries
- Industry
- Chemicals: major diversified
- Address
- 4920 O'Hear Avenue North Charleston SC United States 29405
- IPO Date
- May 2, 2016
- CIK
- 0001653477
- Website
- ingevity.com
- Similar Companies
- Business
- Ingevity Corporation (NYSE: NGVT) manufactures and sells specialty chemicals, activated carbon products, and engineered polymers that purify, protect, and enhance industrial applications worldwide. Founded in 1964 and headquartered in North Charleston, South Carolina, the company operates through three main segments: Performance Materials, offering activated carbon for gasoline vapor emission control in automotive evaporative systems, air and water purification; Advanced Polymer Technologies, providing caprolactone polymers and engineered materials for automotive components, certified biodegradable bioplastics, industrial and consumer plastics enhancement; and Performance Chemicals, supplying emulsifiers, additives, surfactants, and pavement technologies for asphalt paving and infrastructure, oilfield applications, industrial specialties, adhesives, agrochemicals, coatings, elastomers, and pavement markings. Ingevity maintains manufacturing facilities across North America, Europe, and Asia, serving automotive, infrastructure, energy, and industrial markets with approximately 1,600 employees. Recent strategic changes include the announcement in early 2025 to explore divestiture of its Performance Chemicals Industrial Specialties product line and North Charleston crude tall oil refinery to focus on higher-margin specialties, with the sale expected to close by early 2026; expansion of its partnership with CHASM in November 2025 through a licensing agreement for carbon nanotube production to support EV battery materials in North America and Europe, building on a 2024 joint development pact; and ongoing portfolio repositioning with $84 million in cost savings realized in 2024 from Performance Chemicals actions, alongside revised 2025 guidance projecting net sales of $1.25 billion to $1.35 billion and adjusted EBITDA of $390 million to $410 million.
Company News
Ingevity (NGVT) Surpasses Q3 Earnings and Revenue Estimates
Ingevity reports third quarter 2026 financial results
Ingevity Celebrates 10 Years as a Public Company with NYSE Closing Bell® Ringing
NYSE Publishes 'The Busiest Room on Wall Street': NYSE Content Update
Analyzing Mosaic (NYSE:MOS) and Ingevity (NYSE:NGVT)
Is NGVT Positioned for Further Adjusted EBITDA Improvement?
Ingevity Corporation (NYSE:NGVT) Stock Has Consensus Target Price of $80.00 According to Brokerages
Here's Why You Should Hold Onto Ingevity Stock for Now
Ingevity announces dates for third quarter 2026 earnings release and webcast
NGVT Stock Rallies 31% in a Year: What's Driving the Upside?
Ingevity Nears Portfolio Overhaul as Filtration, Warm-Mix Growth Opportunities Emerge
Ingevity Corp (NGVT) Shares Surge 3.4% -- What GF Score of 56 Tells Investors
Ingevity CEO Dave Li to speak at 2026 Water Tower Research Insights Conference
Is Ingevity (NGVT) Stock Outpacing Its Basic Materials Peers This Year?
Ingevity Shares Rise 19.2% YTD: Can the Stock Sustain the Rally?
Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference
Canada Pension Plan Investment Board Makes New Investment in Ingevity Corporation $NGVT
Ingevity (NGVT) Down 0.6% Since Last Earnings Report: Can It Rebound?
Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder
Why You Should Add Ingevity Stock to Your Portfolio Now